Abstract. Laminin-2 is a component of skeletal and cardiac basal lamina expressed in normal mouse and human. Laminin or2 chain (LAMA2), however, is absent from muscles of some congenital muscular dystrophy patients and the dystrophia muscularis (dy/dy) mouse model. LAMA2 restoration was investigated following cell transplantation in vivo in dy/dy mouse.
cardiac basal lamina expressed in normal mouse and human. Laminin or2 chain (LAMA2), however, is absent from muscles of some congenital muscular dystrophy patients and the dystrophia muscularis (dy/dy) mouse model. LAMA2 restoration was investigated following cell transplantation in vivo in dy/dy mouse.
Allogeneic primary muscle cell cultures expressing the 13-galactosidase transgene under control of a muscular promoter, or histocompatible primary muscle cell cultures, were transplanted into dy/dy mouse muscles.
FK506 immunosuppression was used in noncompatible models. All transplanted animals expressed LAMA2 in these immunologicaUy-controlled models, and the degrees of LAMA2 restoration were shown to depend on the age of the animal at transplantation, on muscle pretreatment, and on duration time after transplantation in some cases. LAMA2 did not always colocalize with new or hybrid muscle fibers formed by the fusion of donor myoblasts. LAMA2 deposition around muscle fibers was often segmental and seemed to radiate from the center to the periphery of the injection site. Allogeneic conditionally immortalized pure myogenic cells expressing the 13-galactosidase transgene were characterized in vitro and in vivo. When injected into FK506-immunosuppressed dy/dy mice, these cells formed new or hybrid muscle fibers but essentially did not express LAMA2 in vivo. These data show that partial LAMA2 restoration is achieved in LAMA2-deficient dy/dy mouse by primary muscle cell culture transplantation. However, not all myoblasts, or myoblasts alone, or the muscle fibers they form are capable of LAMA2 secretion and deposition in vivo.
AMININ-2 belongs to the laminin family (Burgeson et al., 1994) and is present in basal laminae of cardiac and skeletal muscle cells (Ehrig et al., 1990) . Some cells of mesenchymal origin, Schwann cells, and thyroid cells would participate in its secretion (Leivo and Engvall, 1988; Engvall, 1993; Andre et al., 1994) . Laminin-2 is constituted by the assembly of three subunits called et2 chain (400 kD), 131, and ~1 chains (200 kD each). Laminins have cross-like three-dimensional structures which interact with cellular receptors such as integrins (Engvall, 1993) . Laminin-2 interacts with the 156-kD dystrophin-associated glycoprotein (o~-dystroglycan; Campbell, 1995) . The laminins promote cell spreading, migration, proliferation, and/or differentiation, and laminin-2 also promotes neurite outgrowth and nerve-muscle interactions (Engvall et al., 1992) . Laminin or2 chain (LAMA2) 1 also promotes Schwann cell migration in vitro and nerve regeneration in vivo (Anton et al., 1994) . The gene coding for human ct2 chain has been cloned and located on chromosome 6 in position q22/ 23. The cDNA is about 9.5 kb in length and encodes for a more than 3,100-amino acid protein (Vuolteenaho et al., 1994) . Hayashi et al. (1993) showed that the LAMA2 expression was reduced in muscle cell basal membranes of some Fukuyama-type congenital muscular dystrophy patients, and Tom6 et al. (1994) showed that LAMA2 expression was deficient in 13 of 20 congenital muscular dystrophy (CMD) patients (i.e., 65%). Out of 25 CMD patients, Sewry et al. (1995) also showed that LAMA2 expression was undetectable in seven and reduced to trace amounts in five. Thus, 48% of CMD patients in this series were deficient for LAMA2 expression. The LAMA2 deficiency has been linked to the Lama2 gene on chromosome 6 (Hillaire et al., 1994) , and a direct implication of the Lama2 gene in the development of the LAMA2-negative CMD has been reported in man (Helbling-Leclerc et al., 1995) . One LAMA2-negative CMD patient also presented LAMA2 mRNA deficiency (Hayashi et al., 1995) . The LAMA2-deficient CMD patients usually have a more severe clinical phenotype than LAMA2-positive CMD patients. They regularly present white matter changes on brain imaging . The identification of mutations on the Lama2 gene could provide a useful tool in categorizing various CMD which show clinical heterogeneity (for review see Dubowitz and Fardeau, 1995; Helbling-Leclerc et al., 1995) . The Fukuyama-type CMD would not be directly linked to the Lama2 gene.
Three groups showed that the dystrophia muscularis (dy/dy) mouse model was deficient for LAMA2 expression Sunada et al., 1994; Xu et al., 1994a) . In these studies, LAMA2 was undetectable in immunohistofluorescence in skeletal and cardiac muscle cell basement membranes and in peripheral nerve and some very low levels of LAMA2 mRNA could be detected only after RT-PCR amplification Xu et al., 1994a) . The LAMA2 deficiency has been linked to the Lama2 gene on chromosome 10 in dy/dy mouse and a mutation has been identified in the dye~ dy 2s mouse, an allelic variant of the LAMA2-negative dy/ dy model (Xu et al., 1994b; Sunada et al., 1995) . First described in 1955, the dy/dy mouse develops early signs of muscular dystrophy (Michelson et al., 1955) . The progressive and lethal dystrophy is characterized first by ataxia, convulsive head movements, spasmodic hind leg flexion, and flaccid extension, followed by progressive muscle atrophy and paralysis extending to axial musculature and anterior legs. At the late stages, the posterior leg locomotion is lost and the mouse develops marked kyphosis. The size, number and diameter of muscle fibers, are greatly variable in dy/dy mice, but always less than in normal mice. The muscles are invaded by connective tissues. The neural system of the dy/dy mice also show many abnormalities. The Schwann cell basal lamina are patchy, and the myelination of the peripheral nervous system is variably defective (Bradley and Jenkison, 1973; Madrid et al., 1975; Montgomery and Swenarchuk, 1977) . The life span of the dyldy mouse is rarely more than six months, and the disease is of autosomal recessive transmission.
The milder allelic variant of the dy/dy mouse, the dy2S/ dy 2s mouse model, express a truncated protein (Xu et al., 1994b; Sunada et al., 1995) . This model would not truly reflect at least the majority of the human CMD because of the expression of a truncated but partially functional LAMA2. Muscle regeneration was investigated in the dy2S/dy 2s mouse following muscle tissue, G8 clonal muscle cells, and primary fetal or newborn muscle cell transplantations (Law, 1982; Law et al., 1988a,b) . The aetiology and molecular basis of this neuromuscular pathology were unknown at the time of these experiments and the use of this animal model seems now partially inadequate. Actually, G8 myoblasts did not form hybrid muscle fibers (Law et al., 1988a) , and some models were not compatible for minor antigens (Law et al., 1988b) . Some, but few animals showed behavioral improvements 2 to 7 mo after transplantation (Law et al., 1988a) .
Myoblast transplantations have been performed in the mdx/mdx mouse, which is a biochemical model of Duchenne muscular dystrophy. Transplantations of cultured muscle cells promoted myoblast fusion, formation of new and/or hybrid muscle fibers in vivo, and intracellular dystrophin restoration in mdxlmdx mice. One of the major drawbacks of myoblast transplantation experiments is the host immune response against donor cells (Kinoshita et al., 1994b; Gu6rette et al., 1995) . Immunosuppressive treatments, immunodeficient or immunocompatible animals, were used to overcome this problem (Partridge et al., 1978 (Partridge et al., , 1989 Grounds et al., 1980; Watt et al., 1984; Morgan et al., 1990 Morgan et al., , 1992 Morgan et al., , 1993 Morgan et al., , 1994 Huard et al., 1994; Kinoshita et al., 1994a,b; Pavlath et al., 1994; Asselin et al., 1995; Vilquin et al., 1995a,c) . Our group has obtained the best success either using FK506 immunosuppression to control nonhistocompatible myoblast transplantation, or using fully compatible host/donor combinations (Kinoshita et al., 1994b; Vilquin et al., 1995c) .
In the present study, LAMA2 restoration in the dy/dy mouse after transplantation of cultured primary muscle ceils was evaluated with respect to age at transplantation, type of transplantation, and muscle pretreatment. In addition, pure myoblast cultures were used to study the role of myoblasts in LAMA2 deposition in vivo.
Materials and Methods

Animals
The C57BI-d6J dy/dy mice (Jackson Laboratories, Bar Harbor, ME) were used as recipients for myoblast transplantation. The C57BL/6J +/+ normal newborn mice (Jackson Laboratories) were used as compatible donors for some myoblast transplantations.
The transgenic TnI-LacZ1/29 mice (Tn-LacZ, gift from K. Hasting, McGill University, Montr6al, Canada) contain the LacZ gene under the control of the quail fast troponin I promoter, thus, myotubes and muscle fibers express a cytoplasmic 13-galactosidase (13-gal) protein (HaUauer et al., 1993; Kinoshita et al., 1994a,b) . I~-gal expression is not restricted to the nucleus in this model. Both male and female parents are heterozygous animals, and newborn mice were used as donors for some immunologically noncompatible myoblast transplantations.
The H-2Kb-tsA58 transgenic mice carry the thermolabile tsA58 mutant of SV40 large T antigen under the control of the H-2K b promoter (Jat et al., 1991) . Interferon ",/ (IFN-~/) increases the transcription of this promoter. The thermolabile protein is functionally active at 33°C but not at 39°C. These characteristics facilitate the derivation of conditionally immortalized cell lines (Morgan et al., 1994 ). An homozygous H-2Kb-tsA58 male mouse (Charles River Lab., Wilmington, MA) was crossed with a heterozygous transgenic Tn-LacZ female mouse. Offsprings were all heterozygous for the H-2Kb-tsA58 transgene and some were heterozygous for the Tn-LacZ transgene. Thus, newborns were tested for 13-gal expression, and only 13-gal positive animals were used for the establishment of myogenic cell lines (see below),
Primary Cell Cultures
Mouse primary myoblast cultures were obtained from biopsies from newborn skeletal muscle as previously described (Vilquin et al., 1995c) . The cell suspension was cultured in 199 medium (GIBCO BRL, Gaithersberg, MD) supplemented with 15% FBS (GIBCO BRL) and antibiotics. Cells were harvested at 70% confluence, that is, 2 d after plating, either for immediate grafting or for freezing until grafting. These cultures were not pure and contained several cell types, with 30-40% being commited myoblasts as assessed by desmin immunostaining (personal results).
Cultures were also obtained from newborn transgenic Tn-LacZ. Because parents were both heterozygous, newborns were individually tested for the expression of 13-gal using X-gal (see below). Only 13-gal-positive newborns were used for primary myoblast cultures. 
Establishment of Permanent Myogenic Cell Lines from (TnI-LacZl129) × (H-2I~-tsA58) Offsprings
Primary muscle cell cultures were started using the 13-gal-positive offsprings. Following preplating, the cells were plated at 50 cells/cm: in gelatin-coated wells and grown in DME (GIBCO BRL) supplemented with 20% FCS and 2% chick embryo extract (GIBCO BRL) at 33~C in 10% CO:. Mouse recombinant IFN-7 (Genzyme Co., Cambridge, MA) was added at the final concentration of 20 U/ml (Morgan et al., 1994) . Colonies of typical myogenic morphology were subsequently cloned in 96-well plates at the limit dilution of one cell per well. The myogenicity of colonies and clones was assessed by desmin immunostaining and by the ability to fuse and form myotubes in vitro. Fusion was obtained by reducing the FCS concentration to 5% and growing the cells at 37°C in 5% CO: in the absence of IFN-~/.
Permanent Fibroblast Cell Lines
Permanent fibroblast cell lines $3T3 and BLK CL.4 were both from American Type Culture Collection (Rockville, MD).
Cell Transplantation
On the day of transplantation, the cells were harvested by trypsinization or thawing, washed three times in HBSS (GIBCO BRL), and concentrated as pellets. Cell viability was assessed using trypan blue staining. The Tibialis anterior (TA) muscles were exposed and injected with approximately 4 × 106 (primary muscle cell cultures), or 106 (myogenic cell lines No. 24, MB7, MB27) or 3 × 106 (myogenic cell line MB3, fibroblast cell lines $3T3, and BLK CL.4) viable cells suspended in 10 Ixl of HBSS. When the role of myoblasts in LAMA2 restoration was explored by clonal cell transplantation, the left TA of the mouse received only myogenic clones, while the right TA received both myogenic clones and a histocompatible primary muscle cell culture (i.e., obtained from normal C57BL6J +/+ newborn mice). Some protocols included v-irradiation and/or notexin treatment of the muscles before cell transplantation: three days before transplantation, one or both hind legs of the dy/dy mice were Cobalt-irradiated (20 Gy). This level of irradiation has been shown to block host myoblast proliferation and to favor donor myoblast implantation (Wirtz et al., 1982; Morgan et al., 1990; Wakeford et al., 1991) ; one day before transplantation, one or both TA were exposed and injected with 10 Ixl of notexin venom (5 p~g/ml), which has been shown to trigger muscle fiber degeneration without damaging myoblasts (Harris et al., 1975) . FK506 immunosuppression was started on the day of transplantation in noncompatible grafting models (2.5 mg/kg/d i.m.; Fujisawa Co, Osaka, Japan; Kinoshita et al., 1994b) . The transplantation schedules are presented in Fig. 1 .
Muscle Collection
At the times indicated, the TA muscles were collected and immersed in a sucrose solution (Tremblay et al., 1993) . Muscles were embedded, frozen in liquid nitrogen, and serially sectioned at 8 p,m. Adjacent serial sections were thus spaced by 8 p,m, while the series of sections were separated by 180 ~m.
~-gal Histochemistry
Differentiated conditionally immortalized myogenic cells and muscle cryostat sections were fixed with 0.25% glutaraldehyde for 3 min and incubated overnight at room temperature with 0.4 mM X-gal (5-bromo-4-chloro-3-indolyl-13-D-galactopyranoside; Boehfinger Mannbeim, Laval, Canada) (Kinoshita et al., 1994a) . Preliminary experiments indicated that the X-gal enzymatic histochemistry was as sensitive as three-step immunohistochemistry using monoclonal anti-13-galactosidase antibodies to localize muscle fibers formed by the fusion of donor myoblasts (not shown). Newborns originating from Tn-LacZ mice were tested for 13-gal expression using the X-gal reagent, except that no fixation was necessary and incubation of a small muscle piece was performed at 37"C for 1 h.
LAMA2 Immunohistochemistry
Muscle sections were fixed in acetone at -20°C for 10 min and then nonspecific Ig binding was blocked with 10% FBS in PBS for 30 rain. The rabbit polyclonal anti-mouse LAMA2 (Xu et al., 1994a) was used 1/300 in PBS containing 1% FBS for 2 h at 37°C. The second antibody was a biotinylated goat anti-rabbit Ig (1/100 in PBS containing 1% FBS for 1 h; Dako, Copenhagen, Denmark). The next step was incubation with streptavidin-HRP or streptavidin-FITC in some cases (1/200 in PBS containing 1% FBS; Dako). Binding was revealed with DAB (0.5 mg/ml; Sigma Chemical Co., St. Louis, MO) and 0.015% hydrogen peroxide. Slides were mounted in PBS-glycerol. Immunoperoxidase-positive and -negative fibers were counted by microscopic examination of each muscle on the section with the most positive fibers.
Desmin Immunocytochemistry
Conditionally immortalized myogenic cells were grown on 2% gelatincoated plates and allowed to fuse in 5% FBS at 37°C. The cells were fixed and permeabilized with methanol at -20°C. Nonspecific binding was blocked using 10% FBS in PBS for 30 rain. The cells were incubated with a mouse anti-desmin antibody (1/50 in PBS containing 1% FBS for 1 h; Dako). The second antibody was FITC-conjugated rabbit anti-mouse IgG (1/100 in PBS containing 1% FBS for 1 h; Dako).
Results
Primary Muscle Cell Culture Transplantation under FK506 Immunosuppression fl-gal Expression.
Primary muscle cell cultures from transgenic mice expressing [5-gal under the control of a musclespecific promoter were able to develop inside the TA muscles of dy/dy mice immunosuppressed with FK506. Some myoblasts fused together or with host muscle fibers to form new or hybrid muscle fibers expressing [3-gal. These I~-gal expressing fibers were not numerous and they were not dispersed throughout muscles (low magnification, Fig.  2 ). They were presumably located only near the injection sites. As seen in Table I , the percentage of 13-gal-positive fibers was rarely higher than 5%. These low percentages were obtained whatever the age of the recipient mice at the time of transplantation, a slight but not significant in- crease was observed when animals were kept longer after transplantation.
LAMA2~:l~ression. As previously reported, LAMA2 was absent from muscles of dy/dy mice Sunada et al., 1994; Xu et al., 1994a,b) and was never expressed in muscles only injected with HBSS (Fig. 3 a) . LAMA2 surrounded normal mouse muscles (Fig. 3 b) . LAMA2 was expressed around some muscle fibers following Tn-LacZ primary muscle cell culture transplantation. The total and relative numbers of LAMA2-positive fibers, however, depended on the age of the mouse at transplantation and on the pretreatment of the muscle (Table I) . The percentage of LAMA2-positive fibers was low (mean +_ SD, 6.4 +_ 4.4) when older animals (i.e., more than 3 mo), were used as recipients (Fig. 3, c and d) . The percentage of LAMA2-positive fibers was higher (15.9 +__ 9.0) when younger animals (i.e., 6 wk old) were used as recipients (Fig. 3, e and f) . Notexin alone, or ~/-irradiation alone, did not increase the number of LAMA2-positive fibers. The combination use of notexin and "~-irradiation increased the percentage of LAMA2-positive fibers in transplanted muscles (27.8 ___ 14.9). There was an overall but not significant increase in the percentage of LAMA2-positive fibers with the duration of the experiment (Table I, the mice in group A all received the same myoblast preparation).
Colocalization of . The Tn-LacZ primary muscle cultures originate from mice with normal LAMA2 expression. Thus, both the normal gene for LAMA2 and the reporter gene coding for I~-gal are present in the donor cells. LAMA2 and 13-gal were characterized on serial sections only spaced by 8 ~m. As shown in Table I , the percentages of LAMA2-positive and l~-gal-positive fibers were comparable when old animals (>3 mo) were used for transplantation. LAMA2 and [~-gal labeling were localized in the same clusters of fibers (Fig. 4) . Some LAMA2-positive fibers, however, were negative for I~-gal expression, and some 13-gal-positive fibers were negative for LAMA2 expression on serial sections (Fig. 4, g and h) . Most of the Cultured cells were injected in one or both TA at the ages indicated, with or without muscle pretreatment. At the times indicated, the mice were sacrificed. The I~-gal-and LAMA2-positive fibers were counted on the best section. *Tx, transplantation. *Notexin indicates uotexin injection and 3,, 3' ray irradiation. smallest fibers were 13-gal positive. These results indicated either that [3-gal and LAMA2 expression were not regulated similarly, or that the same type of cells were not responsible for their expression.
When experiments were designed in younger animals (i.e., 6 wk old), the LAMA2-positive fibers were much more abundant than [3-gal-positive fibers (Table I) . Surprisingly, the pattern and intensity of 13-gal and LAMA2 expression greatly differed. Some LAMA2-positive clusters of fibers were totally devoid of [3-gal (Fig. 4, a-f ). The [3-gal-positive fibers were restricted to smaller areas than LAMA2-surrounded fibers. LAMA2-positive fibers were observed over long distances throughout the muscle, i.e., more than 1,000 I~m, whereas no 13-gal was observed in most of these fibers over all length of LAMA2 expression (Fig. 4, a-f ).
Long-term Histocompatible Transplantations
Transplantation of histocompatible, isogenic primary mouse muscle cells in 6-wk-old male dy/dy mice led to long-term LAMA2 expression (i.e., 11 wk) in the transplanted muscles of all the animals. The percentage of LAMA2-positive muscles was greater when muscles were treated using notexin and ~/-irradiation before transplantation (14.75 _+ 6.4 without pretreatment versus 41.2 _-+ 14.3 with pretreatment). Notexin alone (12.75 --+ 1.2 positive fibers), or irradiation alone (19.25 ___ 6.9 positive fibers), followed by transplantation, was not sufficient to increase dramatically the percentage of LAMA2-positive fibers (Table Ii, Fig. 5, a and b) . Given the small number of dy/ dy mice available for these experiments, however, no statistical analysis was performed.
LAMA2 seemed to have spread centrifugally from the injection site (Fig. 5, e and f) . While LAMA2 completely surrounded normal mouse muscle fibers, its localization was frequently incomplete and disrupted in transplanted dy/dy muscles, especially in case of the largest fibers (Fig.   5, g and h) . Thus, LAMA2 deposition seemed to be localized (Fig. 5, f and g ). LAMA2 deposition also presented important variations in transplanted mice as compared to normal mice. Most of the smallest fibers were totally surrounded by LAMA2 (Fig. 5 g) .
The use of ~/-irradiation and notexin induced some damages into the muscles (Fig. 4, a- Cell cultures were injected in both legs after muscle pretreatment. The mice were killed 11 weeks after transplantation, and LAMA2-positive fibers were counted on the best section. * Tx, transplantation. * Notexin indicates notexin injection, and 3', ~' ray irradiation.
described in the mdx/mdx mouse model, the dy/dy muscle weight was significatively decreased by 30% (mean weight, no pretreatment, 17 _+ 2 mg; -,/-irradiation and notexin 12 _ 2 mg; P < 0.004). It should be noted, however, that dy/ dy muscles already show extensive fibrosis and cellular infiltration in the absence of irradiation and notexin pretreatment ( The transgenic myoblast cultures developed in the present study have the additional advantage that differentiated cells express 13-gal under the control of a specific muscle promoter. This allows the rapid identification of new or hybrid fibers formed by the fusion of these myoblasts in vitro or in vivo in any mouse model. The muscle cells isolated as colonies or single clones from newborn muscles of (Tn-LacZ) X (H-2Kb-tsA58) mice were able to grow and proliferate at 33°C in a 10% CO2 atmosphere when stimulated by murine IFN-% When Myogenic cells were selected in vitro based on desmin expression and the ability to form 13-gal-positive myotubes in differentiation medium. The cells were injected in FK506-immunosuppressed, 4--8-wk-old dy mice with or without addition of primary muscle cell culture, 2, 3, or 4 wk later the mice were sacrificed. [3-gal and LAMA2 expression were investigated on adjacent sections. Typical [3-gal and LAMA2 expression are presented in Pig. 6. * Only the myogenic clone or colony injected. *Myogenic clone or colony injected together with primary muscle cell culture. ~Number of mice expressing LAMA2; (n) total number of mice in one experiment. IINumber of mice expressing 13-gal; (n) total number of mice in one experiment. S2or 3 fibers were faintly surrounded. ND: not done.
shifted to differentiation medium the muscle cells fused together and formed giant myotubes. These cells, either myotubes or myoblasts alone, expressed the intracellular filament desmin, which is an early marker of myoblasts (Fig. 6 , a and b) (Lin et al., 1994) . The myotubes and some early differentiated myoblasts expressed also 13-gal (Fig. 6  c) . The cells were able to fuse and to form new or hybrid muscle fibers expressing [~-gal in vivo in immunodeficient SCID mice without forming solid tumors (Fig. 6 d) . The colony No. 24 (two cells in the original cloning well) and the clones MB3, MB7 and MB27 were selected based on their in vitro myogenic characteristics and were injected into dy/dy muscles.
Lack of LAMA2 Expression Despite Muscle Fiber Formation after Myoblast Clone Transplantations. 2, 3, and 4 wk after injection of conditionally immortalized myoblast
clones into left TA of dy/dy mouse, some [3-gal positive fibers were formed (Fig. 7, a and c, respectively, clones MB27 and MB3, and Table III ). The number of f3-gal positive fibers was low possibly because the muscles were not pretreated with notexin and irradiation. On adjacent sections, however, essentially no LAMA2 could be detected in the same TA muscle, neither surrounding [3-gal-positive fibers or [3-gal-negative fibers (Fig. 7 b, clone MB27 ). LAMA2 was also absent from the series of sections preceeding and succeeding ~-gal-positive sections, thus indicating that a putative difference in the restriction domain of LAMA2 and 13-gal was not responsible for the lack of LAMA2 expression in this model. A very faint labeling could be observed around some, but not all muscle fibers (Fig. 7 d, clone MB3 ) and some of these faintly positive fibers were [3-gal negative. Pure myoblasts were thus able to fuse together or with host muscle fibers and to trigger [3-gal expression, but in most of the cases they did not trigger LAMA2 formation or extracellular deposition at least at levels detectable by immunohistochemistry or immunohistofluorescence (Table III) , The right dy/dy TA of the same mouse, which was injected with a classical histocompatible primary cell culture together with the same myogenic clone MB27, however, contained many LAMA2-surrounded muscle fibers and/or [3-gal-positive fibers (Fig.  7, e and f) . The 13-gal and LAMA2 proteins were not always located in and around the same fibers.
Lack of LAMA2 Expression after Fibroblast Permanent
Cell Lines Transplantations. Permanent fibroblast cell lines $3T3 and BLK CL.4 (both from American Type Culture Collection) were transplanted into dy/dy mice but did not induce LAMA2 production (data not shown). These fibroblast lines, however, may not be representative of all cell types obtained in a primary muscle cell culture.
Discussion
Overall Transplantation Success
Three transplantation models were used in this study. In the first one, nonhistocompatible primary muscle cells expressing the 13-gal under control of a muscular promoter were transplanted into dy/dy mice. This allogenic transplantation required an efficient immunosuppression, which was obtained using FK506 (Kinoshita et al., 1994b; Vilquin et al., 1995b) . The use of 13-gal expressing cells showed the exogenous origin of the labeled muscle fibers and allowed the comparison between LAMA2 and [3-gal localization after transplantation. In the second model, histocompatible syngeneic primary cultures from normal littermates were transplanted into dy/dy mice. This model did not require immunosuppression and allowed the study of muscle regeneration over longer time. In the third model, pure but nonhistocompatible myoblasts were transplanted into one leg of FK506-immunosuppressed dy/dy mice, whereas the other leg received histocompatible primary culture as a control of LAMA2 expression. This model allowed the direct comparison of the outcome of transplantation between pure myoblast and primary muscle cells and allowed the investigation of the potential role of myoblasts in LAMA2 deposition.
Cell transplantation allowed the restoration of a structural, extracellular protein. In these immunologically controlled models the transplantation of primary muscle cells led to LAMA2 expression in variable amounts in all animals. The number of LAMA2-surrounded fibers was shown to depend on the age of the animal at the time of transplantation and on the muscle pretreatment. The highest numbers of LAMA2-surrounded fibers were obtained when young animals (6 wk old) received histocompatible cells after ",/-irradiation and notexin pretreatment of the muscle. Irradiation was shown to hamper myoblast proliferation and thus reduce normal muscle regeneration, and to favor extensive fibrosis in dy/dy (Wirtz et al., 1982) and mdx/mdx (Wakeford et al., 1991) mice. This treatment greatly increased donor myoblast permeation into host degenerating fibers and the formation of new or hybrid dystrophin-positive fibers in mdx/mdx mice (Morgan et al., 1990) . In our models, it is thus likely that irradiation and notexin necrosis initially favor donor cell development in vivo over the dy/dy recipient cells.
In the histocompatible model LAMA2, which is the only known difference between dy/dy host mice and +/? donor mice, is not sufficient to trigger efficient acute rejection of LAMA2-expressing cells. Interestingly, the mice did not produce antibodies directed against LAMA2 (not shown). Chronic rejection was not assessed in this study, but the overall highest numbers and percentages of LAMA2-surrounded fibers were observed after the longest survival time (i.e., 11 wk after grafting). LAMA2 is undectable in immunohistochemistry but very low amounts of LAMA2 mRNA are detected in untreated dy/dy mice by RT-PCR Xu et al., 1994a) . The reason why the transplanted animals are tolerant to LAMA2 is not known.
The intensity of [3-gal staining and the number of 13-galpositive fibers after transgenic Tn-LacZ culture transplantation was low as compared to results obtained in other, non dy/dy mice strains under the same FK506 immunosuppressive treatment. In a previous report, up to 90% of mdx/mdx TA muscle fibers could express 13-gal only one month after transplantation (Kinoshita et al., 1994b) . The present results suggest that muscle cell transplantation is less efficient in dy/dy mouse than in mdx. Actually, more than 1,000 dystrophin-positive fibers are frequently obtained in only 2 mo after histocompatible primary muscle culture transplantation in mdx/mdx mice (Vilquin et al., 1995c) , whereas it is difficult to obtain more than 300 to 400 LAMA2-surrounded muscle fibers in the same time in dy/dy mice. The humoral and cellular immune reactions against [3-gal and MHC proteins are very efficiently controlled by FKS06 in various transplantation models, animals, or mouse strains (Kinoshita et al., 1994b Asselin et al., 1995; Vilquin et al., 1995b,c) . Thus, immune rejection is not likely to be the cause of the relatively poor cellular engraftment in immunosuppressed dy/dy mouse as compared to mdx/mdx mouse. The dy/dy muscle fibers are smaller than normal muscle fibers and they show important size variation within a single muscle (Michelson et al., 1955; see also Fig. 5, c and d) . This may reflect trophic problems in dy/dy muscles related to the absence of LAMA2 in basal lamina that could explain the variation in regeneration efficiency between the mdx/mdx and the dy/ dy models. First, the initial lack of LAMA2 could hamper myoblast migration or alignment either with other myoblasts or with host muscle fibers, because basal lamina is known to play important roles in the control of migration, proliferation and differentiation of various cell types (Engvail et al., 1992) . Thus, the lack of LAMA2 could hamper regeneration. Muscle regeneration could depend on the presence of a pre-existing complete basal lamina. Second, an impaired muscle innervation due to the absence of LAMA2 around peripheral nerve fibers or neuromuscular junctions (Leivo and Engvall, 1988; Sunada et al., 1994; Xu et al., 1994a) could induce a muscle atrophy. Third, the myoblast proliferation and/or migration could be impaired by the abundant connective tissues, present especially in the oldest dy/dy mice. Taken together, these problems may explain why muscle regeneration was relatively poor following transplantation, whatever the pretreatment used.
LAMA2 and fl-gal Colocalization after Transplantation of Transgenic Primary Cells
In transplanted muscle, LAMA2 was generally more widely distributed than 13-gal. This could indicate differences in the regulation of expression of these two proteins, that LAMA2 but not 13-gal can diffuse extracellularly, or that the cell type responsible for LAMA2 expression is not the cell type responsible for [3-gal expression. Although the [3-gal gene in the TnI-LacZ1/29 mice is under the control of the promoter of the quail fast troponinI, the [3-gal was reported to be expressed in all fiber types by Hallauer et al. (1993) . Moreover, transgenic [3-gal myoblast transplantation into the TA of mdx/mdx mice under FK506 immunosuppression was reported to lead to the strong expression of t3-gal in as much as 90% of the fibers within one month, thus probably including both fast and slow muscle fibers (Kinoshita et al., 1994b) . 13-gal expression is restricted to skeletal muscle cells as an intracellular protein, and its nuclear domain is ~1,000 ~m (Kinoshita, I., personal results). In contrast, laminins and likely LAMA2 are secreted outside of the cells, and may have a relatively long half-life in vivo (Engvall, 1993) as components of muscle cells basal lamina. Thus, the fate of [3-gal and LAMA2 in vivo is probably different. Whereas [3-gal expression requires myoblast fusion and formation of hybrid or new muscle fibers, the developmental mechanisms of LAMA2 expression are still unclear.
[3-gal and LAMA2 did not always colocalize in and around the same segments of muscle fibers. On serial sections 13-gal-positive segments of fibers could be LAMA2 negative and vice versa. Thus, either myoblasts and muscle fibers do express both [3-gal and LAMA2, or these proteins are expressed by several or only partially overlapping different cell types, or by cells at different stages of differentiation. If muscle cells express both LAMA2 and [3-gal, then 13-gal-positive fibers should be surrounded by LAMA2, even on short muscle fiber segments. This was not always observed. The other hypothesis implies that myoblasts and muscle fibers should express 13-gal, whereas other cells should secrete LAMA2. Depending on the presence and development of myoblasts, or LAMA2-secreting cell, or both cell types in the vicinity of host muscle fibers after transplantation of primary muscle cell culture, t3-gal-positive, or LAMA2 positive, or both 13-gal-and LAMA2-positive fibers should be observed.
LAMA2 Expression Pattern
LAMA2 generally deposited continuously around small caliber muscle fibers, whereas this deposition was frequently discontinuous around normal diameter muscle fibers, even two months after transplantation (Fig. 5, e and  f) . In contrast, dystrophin was expressed along the complete inner circumference of muscle fibers by some weeks after transplantation, and dystrophin disruption was rarely observed one or several months after transplantation in the mdx/mdx or SCID mouse models (Partridge et al., 1989; Morgan et al., 1990 Morgan et al., , 1993 Morgan et al., , 1994 Huard et al., 1994; Kinoshita et al., 1994b; Vilquin et al., 1995c) . The expression of LAMA2 seemed to occur in a radial manner from the site of injection. This observation suggests that competent cells could proliferate and diffuse, or that the secre-tion product may diffuse, thus producing a gradient of LAMA2 expression that would progressively accumulate around the most proximal muscle fibers.
Role of Myoblasts in LAMA2 Restoration in dyldy Mice
Cloned myogenic cells formed new or hybrid [3-gal-posirive muscle fibers following transplantation into dy/dy mice. Small and normal caliber [3-gal-positive fibers were obtained already 2 wk after transplantation. Small-caliber fibers were likely entirely of donor origin. Normal-caliber fibers probably originated from the fusion of donor myoblasts with host muscle fibers undergoing a segmental degeneration-regeneration process at the site of injection. The 13-gal-positive fibers, however, were very rarely surrounded by LAMA2, thus indicating that myoblasts and muscle fibers formed by them were not able to secrete LAMA2, at least to levels detectable by immunohistochemistry and immunohistofluorescence. As a control for LAMA2 expression, primary cells from mixed cultures injected in the contralateral leg were able to trigger LAMA2 deposition around new and hybrid muscle fibers within 2 wk. Thus, LAMA2 may be secreted by some competent cells present in primary culture, but not in cloned myoblasts. Another hypothesis which cannot be ruled out yet, is that none of the myogenic clones used in this study was able to produce LAMA2 in vivo, despite their ability to express desmin, to express [3-gal under control of a muscular promoter, to form myotubes in vitro and to form muscle fibers in vivo. Indeed, some distinct populations of satellite cells have been described in regenerating rat skeletal muscle (Rantanen et al., 1995) . The secretion of LAMA2 could be dependent on cell differentiation status and could be regulated in myogenic cells, as are other muscle proteins and myogenic factors (Rantanen et al., 1995) . This hypothesis would be supported by the very faint labeling observed around 2 or 3, but not all, muscle fibers following clone MB3 and clone MB7 transplantation, and is currently under investigation.
Future Prospects
The transplantation models and results presented in this article should prove useful to study in vivo interactions between muscle cells and extracellular matrix. The critical steps for normal and pathologic muscle regeneration, that is, myoblast proliferation, alignment or fusion, or the stability of nerve-muscle regulations, should be discriminated.
The identification of the cell type responsible for LAMA2 secretion and its relation with other muscle constituents are important future issues, and could help to categorize clinical cases of CMD and develop new strategies for the correction of muscular diseases by gene complementation. Long-term experiments should also be designed to improve the transplantation results. The leasability of myelination restoration in the peripheral nervous system of the dy/dy mouse should be assessed (Bradley and Jenkison, 1973; Sunada et al., 1995) . Alternatively, the transducibility of the LAMA2-secreting cell type by different gene vectors (adenoviruses, retroviruses, herpesviruses) should indicate if it could constitute a good target candidate for in vivo or ex vivo gene therapy of CMD.
Pancreatic islet cells, embryonic neurons, myoblasts, hematopoietic bone marrow stem cells transplantations are currently investigated as potential avenues for the treatment of inherited or acquired diseases. Only further studies will indicate if some extracellular matrix pathologies could be rescued by cell transplantation.
